ICU Medical Inc
ICUI129.435USD
+2.035+1.60%
Horário de mercado （ET）Cotações atrasadas em 15 min
3.19BValor de mercado
PerdaP/L TTM
Mais detalhes de ICU Medical Inc Empresa
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
Informações da empresa
Código da empresaICUI
Nome da EmpresaICU Medical Inc
Data de listagemMar 31, 1992
CEOMr. Vivek Jain
Número de funcionários15000
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 31
Endereço951 Calle Amanecer
CidadeSAN CLEMENTE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal92673-6212
Telefone19493662183
Sitehttps://www.icumed.com/
Código da empresaICUI
Data de listagemMar 31, 1992
CEOMr. Vivek Jain
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
196.92K
+1.88%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
14.19K
+30.63%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
7.26K
+31.12%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
3.61K
+91.41%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
3.29K
+110.31%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
3.25K
+52.75%
Mr. Donald M. Abbey
Mr. Donald M. Abbey
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
196.92K
+1.88%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
14.19K
+30.63%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
7.26K
+31.12%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
266.23M
44.03%
Vital Care
172.18M
28.47%
Infusion Systems
166.30M
27.50%
Por RegiãoUSD
Nome
Receita
Proporção
United States
388.25M
64.20%
EMEA
95.69M
15.82%
Others
61.36M
10.15%
APAC
59.41M
9.82%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
266.23M
44.03%
Vital Care
172.18M
28.47%
Infusion Systems
166.30M
27.50%
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.27%
The Vanguard Group, Inc.
10.71%
Janus Henderson Investors
10.03%
Fuller & Thaler Asset Management Inc.
5.62%
State Street Global Advisors (US)
3.65%
Other
56.71%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.27%
The Vanguard Group, Inc.
10.71%
Janus Henderson Investors
10.03%
Fuller & Thaler Asset Management Inc.
5.62%
State Street Global Advisors (US)
3.65%
Other
56.71%
Tipos de investidores
Investidores
Proporção
Investment Advisor
48.22%
Investment Advisor/Hedge Fund
42.32%
Hedge Fund
6.10%
Research Firm
2.56%
Corporation
1.91%
Pension Fund
1.35%
Individual Investor
1.14%
Sovereign Wealth Fund
1.10%
Bank and Trust
0.55%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
607
25.92M
105.32%
-2.09M
2025Q1
626
27.13M
110.25%
-2.28M
2024Q4
608
26.46M
107.92%
-3.56M
2024Q3
587
26.75M
109.35%
-2.77M
2024Q2
567
27.24M
111.60%
-1.50M
2024Q1
579
26.01M
106.82%
-1.69M
2023Q4
588
25.74M
106.69%
-1.14M
2023Q3
580
26.53M
109.94%
-1.49M
2023Q2
580
26.62M
110.47%
-2.27M
2023Q1
598
27.04M
112.38%
-1.56M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
3.27M
13.27%
-99.77K
-2.96%
Mar 31, 2025
The Vanguard Group, Inc.
2.64M
10.71%
-39.79K
-1.49%
Mar 31, 2025
Janus Henderson Investors
2.47M
10.03%
+18.73K
+0.76%
Apr 30, 2025
Fuller & Thaler Asset Management Inc.
1.38M
5.62%
-11.46K
-0.82%
Mar 31, 2025
State Street Global Advisors (US)
899.31K
3.65%
-36.99K
-3.95%
Mar 31, 2025
Fidelity Management & Research Company LLC
727.77K
2.96%
+337.67K
+86.56%
Mar 31, 2025
Columbia Threadneedle Investments (US)
671.44K
2.73%
+108.47K
+19.27%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
631.48K
2.57%
+91.50K
+16.94%
Mar 31, 2025
Schroder Investment Management North America Inc.
621.95K
2.53%
+122.18K
+24.45%
Mar 31, 2025
JP Morgan Asset Management
621.77K
2.53%
+36.93K
+6.32%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Invesco S&P SmallCap Health Care ETF
2.33%
SPDR S&P Health Care Equipment ETF
1.79%
Invesco S&P SmallCap Momentum ETF
0.78%
Invesco S&P SmallCap 600 Pure Growth ETF
0.75%
JPMorgan Active Small Cap Value ETF
0.74%
JPMorgan Fundamental Data Science Small Core ETF
0.71%
Zacks Small/Mid Cap ETF
0.65%
SPDR S&P 600 Small Cap Growth ETF
0.47%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.47%
iShares S&P Small-Cap 600 Growth ETF
0.45%
Ver Mais
Invesco S&P SmallCap Health Care ETF
Proporção2.33%
SPDR S&P Health Care Equipment ETF
Proporção1.79%
Invesco S&P SmallCap Momentum ETF
Proporção0.78%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporção0.75%
JPMorgan Active Small Cap Value ETF
Proporção0.74%
JPMorgan Fundamental Data Science Small Core ETF
Proporção0.71%
Zacks Small/Mid Cap ETF
Proporção0.65%
SPDR S&P 600 Small Cap Growth ETF
Proporção0.47%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporção0.47%
iShares S&P Small-Cap 600 Growth ETF
Proporção0.45%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
